| Literature DB >> 24962272 |
Tae Hyung Won1, Minjung You2, So-Hyoung Lee3, Boon Jo Rho4, Dong-Chan Oh5, Ki-Bong Oh3, Jongheon Shin6.
Abstract
Seven new amino alcohol compounds,Entities:
Mesh:
Substances:
Year: 2014 PMID: 24962272 PMCID: PMC4071600 DOI: 10.3390/md12063754
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–16.
13C NMR (ppm, mult) Assignments for Compounds 1–7 .
| Position | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 15.7, CH3 | 15.8, CH3 | 15.7, CH3 | 45.3, CH2 | 15.7, CH3 | 12.7, CH3 | 12.9, CH3 |
| 2 | 53.3, CH | 52.7, CH | 53.3, CH | 68.7, CH | 53.6, CH | 57.8, CH | 57.8, CH |
| 3 | 75.0, CH | 73.1, CH | 74.6, CH | 39.4, CH2 | 74.6, CH | 72.2, CH | 72.1, CH |
| 4 | 129.8, CH | 38.0, CH2 | 129.7, CH | 125.6, CH | 130.1, CH | 129.4, CH | 130.4, CH |
| 5 | 137.2, CH | 125.7, CH | 135.6, CH | 135.4, CH | 135.5, CH | 134.0, CH | 132.8, CH |
| 6 | 33.3, CH2 | 135.5, CH | 130.6, CH | 33.6, CH2 | 130.9, CH | 31.2, CH2 | 129.8, CH |
| 7 | 30.1 | 33.7, CH2 | 137.8, CH | 30.5 | 137.0, CH | 28.5 | 134.8, CH |
| 8 | 30.3 | 30.6 | 33.6, CH2 | 30.4 | 33.7, CH2 | 28.5 | 32.1, CH2 |
| 9 | 30.4 | 30.6 | 30.3 | 30.3 | 27.9, CH2 | 28.6 | 26.4, CH2 |
| 10 | 30.6 | 30.4 | 30.3 | 30.2 | 129.9, CH | 28.8 | 129.0, CH |
| 11 | 30.7 | 30.3 | 30.3 | 32.9, CH2 | 129.7, CH | 28.9 | 128.3, CH |
| 12 | 33.1, CH2 | 33.1, CH2 | 33.0, CH2 | 23.6, CH2 | 26.4, CH2 | 31.6, CH2 | 25.2, CH2 |
| 13 | 23.7, CH2 | 23.7, CH2 | 23.7, CH2 | 14.3, CH3 | 128.3, CH | 22.1, CH2 | 127.1, CH |
| 14 | 14.4, CH2 | 14.4, CH3 | 14.4, CH3 | 132.6, CH | 13.9, CH3 | 131.5, CH | |
| 15 | 21.5, CH2 | 20.1, CH2 | |||||
| 16 | 14.6, CH3 | 14.2, CH3 | |||||
| 1′ | 46.5, CH2 | 46.7, CH2 | |||||
| 2′ | 168.0, C | 168.5, C |
Data were obtained in MeOH-d4 (1–5) and DMSO-d6 (6, 7) solutions; Interchangeable signals.
1H NMR (ppm, mult) Assignments for Compounds 1–3 .
| Position | 1 | 2 | 3 |
|---|---|---|---|
| 1 | 1.22, d (7.0) | 1.26, d (7.0) | 1.22, d (7.0) |
| 2 | 3.08, dq (7.5, 7.0) | 3.11, dq (3.0, 7.0) | 3.10, dq (7.5, 7.0) |
| 3 | 3.88, dd (7.0, 7.0) | 3.50, dd (5.0, 7.0, 7.0) | 3.90, dd (7.5, 7.5) |
| 4 | 5.42, dd (7.5, 15.5) | 2.33, ddd (7.0, 7.0, 14.5); 2.17, ddd (7.0, 7.0, 14.5) | 5.51, dd (7.5, 15.0) |
| 5 | 5.83, td (7.0, 15.5) | 5.48, dt (7.0, 7.0, 15.0) | 6.33, dd (11.0, 15.0) |
| 6 | 2.09, td (7.5, 7.0) | 5.57, dt (7.0, 7.0, 15.0) | 6.00, dd (11.0, 15.0) |
| 7 | 1.34, tt (7.5, 7.5) | 2.03, dt (7.0, 7.0) | 5.78, dd (7.5, 15.0) |
| 8 | 1.23–1.27, m | 1.26–1.32, m | 2.09, dt (7.0, 7.0) |
| 9 | 1.23–1.27, m | 1.26–1.32, m | 1.38, tt (7.0, 7.0) |
| 10 | 1.23–1.27, m | 1.26–1.32, m | 1.26–1.32, m |
| 11 | 1.23–1.27, m | 1.26–1.32, m | 1.26–1.32, m |
| 12 | 1.23–1.27, m | 1.26–1.32, m | 1.26–1.32, m |
| 13 | 1.23–1.27, m | 1.26–1.32, m | 1.26–1.32, m |
| 14 | 0.89, t (7.0) | 0.89, t (7.0) | 0.89, t (7.0) |
Data were obtained in MeOH-d4 solutions.
Scheme 1Reagents and Conditions: 1,1′-carbonyldiimidazole, CH2Cl2, rt, 2 h.
Scheme 2Reagents and Conditions: (a) H2, Pd/C, MeOH, rt, 2 h; (b) acetic anhydride, pyridine, rt, 1 h; (c) MTPA-Cl, pyridine, DMAP, rt, 1 h; (d) benzoyl chloride, pyridine, DMAP, rt, 3 h.
Figure 2The Result (∆δ) of MTPA esterification for compound 11.
Figure 3The CD spectrum of compound 12.
1H NMR (ppm, mult) Assignments for Compounds 4–7 .
| Position | 4 | 5 | 6 | 7 |
|---|---|---|---|---|
| 1 | 2.74, dd (10.0, 13.0); 3.00, dd (3.0, 13.0) | 1.23, d (7.0) | 1.10, d (7.0) | 1.22, d (7.0) |
| 2 | 3.76, dddd (3.0, 7.0, 7.0, 10.0) | 3.11, dq (7.5, 7.0) | 2.98, dq (7.5, 7.0) | 2.99, dq (7.5, 7.0) |
| 3 | 2.24, ddd (7.0, 7.0, 14.0); 2.19, ddd (7.0, 7.0, 14.0) | 3.96, dd (7.5, 7.5) | 3.88, dd (7.5, 7.5) | 4.02, dd (7.5, 7.5) |
| 4 | 5.44, ddd (7.0, 7.0, 15.0) | 5.53, dd (7.5, 15.0) | 5.37, dd (15.0, 7.5) | 5.53, dd (15.0, 7.5) |
| 5 | 5.56, dt (15.0, 7.0) | 6.32, dd (10.5, 15.0) | 5.68, ddd (7.0, 7.0, 15.0) | 6.21, dd (11.0, 15.0) |
| 6 | 2.02, dt (7.0, 7.0) | 6.11, dd (10.5, 15.0) | 2.00, ddd (7.0, 7.0, 15.0) | 6.06, dd (11.0, 15.0) |
| 7 | 1.35, tt (7.0, 7.0) | 5.78, dt (15.0, 7.0) | 1.33, m | 5.73, dd (7.5, 7.5) |
| 8 | 1.25–1.33, m | 2.16, s | 1.23–1.28, m | 2.11, br s |
| 9 | 1.25–1.33, m | 2.16, s | 1.23–1.28, m | 2.11, br s |
| 10 | 1.25–1.33, m | 5.35, m | 1.23–1.28, m | 5.33, m |
| 11 | 1.25–1.33, m | 5.35, m | 1.23–1.28, m | 5.33, m |
| 12 | 1.25–1.33, m | 2.77, dd (6.0, 6.0) | 1.23–1.28, m | 2.73, dd (6.0, 6.0) |
| 13 | 0.89, t (7.0) | 5.31, m | 1.23–1.28, m | 5.25, dt (10.0, 6.0) |
| 14 | 5.35, m | 0.84, t (7.0) | 5.33, m | |
| 15 | 2.06, dq (7.0, 7.0) | 2.02, dq (7.0, 7.0) | ||
| 16 | 0.96, t (7.0) | 0.91, t (7.0) | ||
| 1′ | 3.35, d (15.0) | 3.34, d (15.0) | ||
| 3.23, d (15.0) | 3.23, d (15.0) |
Data were obtained in MeOH-d4 (4, 5) and DMSO-d6 (6, 7) solutions.
Scheme 3Reagents and Conditions: (a) H2, Pd/C, MeOH, rt, 2 h; (b) acetic anhydride, pyridine, rt, 1 h; (c) MTPA-Cl, pyridine, DMAP, rt, 1 h; (d) benzoyl chloride, pyridine, DMAP, rt, 3 h.
Figure 4The Result (∆δ) of MTPA esterification for compound 15.
The Result of Bioactivity test.
| LC50 (μM) | MIC (μg/mL) | IC50 (μM) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| K562 | A549 | Gram(+) Bacterium | Gram(−) Bacterium | Na+/K+-ATPase | |||||
| Compound | A | B | C | D | E | F | |||
|
| 13.6 | 13.8 | 12.5 | 25 | 12.5 | 6.25 | 25 | >100 | 62.0 |
|
| 12.6 | 13.1 | 12.5 | 25 | 12.5 | 12.5 | 25 | >100 | 78.4 |
|
| 12.4 | 12.4 | 50 | 100 | 100 | 50 | 100 | >100 | >200 |
|
| 11.9 | 13.2 | 100 | >100 | 100 | 50 | >100 | >100 | 190.3 |
|
| >100 | 12.3 | 100 | >100 | 100 | 50 | >100 | >100 | 101.2 |
|
| >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >200 |
|
| >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >200 |
|
| 12.7 | 10.5 | 50 | 50 | 25 | 12.5 | 50 | >100 | 71.4 |
|
| >100 | 14.0 | 12.5 | 25 | 12.5 | 6.25 | 25 | >100 | 46.8 |
|
| 17.3 | 11.7 | 50 | 100 | 100 | 50 | 100 | >100 | 118.1 |
|
| 5.9 | 8.0 | >100 | >100 | >100 | >100 | >100 | >100 | 108.2 |
|
| >100 | >100 | 100 | >100 | 100 | 100 | >100 | >100 | 130.3 |
|
| >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >200 |
| Doxorubicin | 1.1 | 0.9 | |||||||
| Ouabain | 6.1 | ||||||||
| Ampicillin | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 | 6.3 | |||
A: Staphylococcus aureus (ATCC 6538p); B: Bacillus subtilis (ATCC 6633), C: Micrococcus luteus (IFO 12708); D: Salmonella typhimurium (ATCC 14028); E: Proteus vulgaris (ATCC 3851); F: Escherichia coli (ATCC 35270).